Clinical Trials Logo

Clinical Trial Summary

The objective of this study is quantification of singlet oxygen species in the skin after exposure to Ultraviolet A (UVA) light


Clinical Trial Description

Ultraviolet (UV) radiation can lead to skin damage and cancer. Ultraviolet A (UVA) irradiation is 10 to 100 times more abundant in natural sunlight than ultraviolet B (UVB), thus human skin is exposed to more UVA irradiation daily.UVA irradiation is not completely filtered by clothing and it penetrates deeper into the dermis than UVB, potentially causing more damage. It is believed that skin cancer, photo aging, and skin immunomodulation are mediated by the reactive oxygen species (ROS) that are generated in response to UV radiation. Singlet oxygen (1O2) is one type of ROS. The aim of this study is to quantify the level of singlet oxygen generated in the skin after exposure to UVA radiation. Previous studies have used low dose ultraviolet A1(UVA1) irradiation of 20 J/cm2, which mimics exposure to strong sunlight of approximately two hours. This study will use UVA doses equivalent to or less than what humans are exposed to in daily life. Additionally, the aim is to quantify singlet oxygen produced in individuals of various skin types before and after application of sunscreens containing zinc oxide and avobenzone (sun protection factor 30). To our knowledge, there is no method for quantifying singlet oxygen in human skin after exposure to UVA light. This is a novel method that may help the investigators understand further the protective effects of various skin types, as well as sunscreens. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05865431
Study type Interventional
Source University of California, Davis
Contact
Status Completed
Phase N/A
Start date March 17, 2017
Completion date February 2, 2018

See also
  Status Clinical Trial Phase
Active, not recruiting NCT04181476 - Efficacy Evaluation of Products Against Long Wavelength Ultraviolet A1 and Visible Light Induced Biological Effects Phase 2
Completed NCT05300542 - Efficacy Study of a Novel Skin Health Product to Reduce an UVB Induced Erythema N/A
Completed NCT05926791 - Photoprotective Effects of a SPF50+ Sunscreen on Skin Genotoxicity Induced by Repeated Chronic Outdoor Sun Exposure
Completed NCT05398237 - An Assessment of TLR4 and TOPK/PRPK Signaling in Sun Damaged Human Skin Acutely Exposed to Solar Simulated Light N/A
Completed NCT05162300 - Same-Day Combination of VI Peel and Botox for Correction of Sun Damage, Fine Lines and Wrinkles Phase 4
Completed NCT03110159 - DUSA: Cyclic PDT for the Prevention of AK & NMSC in Solid Organ Transplant Recipients Phase 1/Phase 2
Completed NCT03006185 - Laser and Microdermabrasion Before Photodynamic Therapy for Actinic Keratoses in Field-cancerized Skin Phase 2
Enrolling by invitation NCT03007589 - Natural Sunlight Protection and Simulated Sunlight Protection Offered by Sunscreens and Fabrics N/A